Nanfang Hospital, Southern Medical University: Graft vs Host Disease trials

The registry lists 10 Graft vs Host Disease studies with Nanfang Hospital, Southern Medical University as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 2 4Phase 3 1Phase 4 2No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Tissue-resident Immune Cell Subsets in aGVHDRecruitingNCT06708507
• The Safety and Efficacy of Fecal Microbiota Transplant (FMT) for Steroid-refractory Graft-versus-host DiseaseCompletedNCT06938165Not applicable
• Donor Neutrophil Subsets to Predict the Risk of aGVHDActive, not recruitingNCT06394895
• MSC for Treatment of cGVHD After Allo-HSCTStatus unknownNCT04692376Phase 2
• Efficacy and Safety of FMT Capsule Treating Steroid-refractory GI-aGvHDStatus unknownNCT04622475Not applicable
• PTCy-ATG vs ATG in Haploidentical HSCT for Acute Graft-versus-host Disease ProphylaxisStatus unknownNCT03689465Phase 4
• MSCs Combined With CD25 Monoclonal Antibody and Calcineurin Inhibitors for Treatment of Steroid-resistant aGVHDStatus unknownNCT02241018Phase 2/3
• ATG in Haploidentical HSCT for Acute Graft-versus-host Disease ProphylaxisCompletedNCT01883180Phase 4
• Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host DiseaseStatus unknownNCT01765660Phase 2
• Mesenchymal Stem Cells for Treatment of Refractory Acute Graft-versus-host DiseaseStatus unknownNCT01765634Phase 2